Lima Corporate said today private equity firm EQT acquired it through the purchase of the majority of the company’s shares, shifting ownership from Ardian.
The transaction is still subject to regulatory approval in European jurisdictions, the company said.
“EQT has followed Lima for almost ten years and we are impressed by the Company’s growth history as well as the strength of the management team. We are now keen to support Lima in its next phase of development. Lima is well-positioned for future growth and we are convinced it can be accelerated by leveraging our industrial network and resources. We look forward to working with the management team to achieve the full potential of Lima,” EQT partner Michael Bauer said in a press release.
“I have to thank all the people that have believed in Lima Corporate, from our board to our shareholders to our surgeons and our employees. By working together, we are confident to continue to provide surgeons and their patients the most effective and safest implant technology on the market today,” Lima CEO Luigi Ferrari said in prepared remarks.
Earlier this month, Lima said it closed its purchase of Zimmer Biomet‘s (NYSE:ZBH) unicompartmental high flex knee and discovery elbow systems in the Japanese market, as well as the Japanese supply chain.
The deal closed after receiving approval from the Japanese Fair Trade Commission, Italian Lima said.
In July, Lima said it completed its acquisition of knee and elbow assets from Zimmer Biomet.
The Italian orthopedic company said it purchased Zimmer’s unicompartmental High Flex knee implant and Biomet’s Discovery elbow system within the European Economic Area and Switzerland. Lima Corporate also acquired Biomet’s Vanguard complete knee system in Denmark and Sweden.